News

Deal Announcements

InterValve Secures $3 Million Venture Capital Debt

Tuesday, January 27, 2015 5:46:00 AM PDT | VentureDeal
   Minnetonka, Minnesota  --  Medical device technology company InterValve has received $3 million in venture capital debt investment.

InterValve is developing a next-generation aortic valvuloplasty balloon for the treatment of calcific aortic stenosis.

Oxford Finance made the loan.

InterValve said it would use the funding proceeds for product line expansion and the ongoing commercialization of its lead balloon catheter.

The company's previous financing event was an undisclosed amount of funding received in August, 2014.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1